Endocrine System Diseases  >>  Ovidrel (choriogonadotropin alfa)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ovidrel (choriogonadotropin alfa) / EMD Serono
NCT00328926: LuverisĀ® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])

Terminated
4
11
US
LuverisĀ® 75 IU, Lutropin alfa, Recombinant human luteinizing hormone (r-hLH), LuverisĀ® 25 IU, Placebo, Recombinant human follicle stimulating hormone (r-hFSH), Follitropin alfa, Recombinant human chorionic gonadotropin (r-hCG), Choriogonadotropin alfa
EMD Serono
Hypogonadotropic Hypogonadism
05/12
05/12

Download Options